North America Sleep Apnea Devices Market

North American Sleep Apnea Devices Market Size (2022 to 2027) 

The size of the North American Sleep Apnea Devices Market was valued at USD 3.47 billion in 2022. This value is expected to grow at a CAGR of 8.1% to reach USD 5.12 billion by 2027.

Sleep apnea is a sleeping disorder that interrupts the breath by blocking the flow of the air. Sleep apnea devices use continuous positive airway pressure (CPAP), which helps the patient breathe easily.

The increasing number of people suffering from sleeping disorders, especially younger generations, leads to a constant demand for sleep apnea devices. The novel and advanced methods are continually flowing into the market due to the focused research and development activities, propelling the growth of the sleep apnea devices market in North America. The availability of advanced healthcare facilities, hospitals, and diagnostics centers in North America is also a significant factor that boosts the growth rate of the sleep apnea devices market in this region. 

Patients feeling discomfort while using masks and high initial set up costs and maintenance costs of sleep apnea devices like CPAP, complications in therapies, are expected to limit the growth of the sleep apnea devices market in North America during the forecast period.

Unhealthy sleeping habits among many individuals and a rise in disposable income are anticipated to boost the market demand and provide lucrative growth opportunities for the key players in the market over the forecast period. R&D organizations and academic institutions focus on developing innovative products with advanced technology to enhance the efficiency of diagnosis, therapies, and devices such as smartphone assistance through the internet are boosting demand and improving the growth opportunities for the stakeholders and key players of the sleep apnea devices market in North America. 

U.S. Sleep Apnea Devices Market:

The U.S. Sleep Apnea Devices Market is forecasted to be growing at a CAGR of 9.1% between 2020 to 2025 and was occupied the majority of the share in the North American market in 2019. In the US, approximately 22 million people are getting treatment for obstructive sleep apnea (OSA). Around 80% of them have moderate symptoms, whereas the rest are suffering from severe OSA cases. 85% of people are left undiagnosed in most of the countries in North America.

Adopting sedentary lifestyles and changes in food habits leads to various health disorders like obesity, diabetes, and others. Particularly in the US, more than 70 million adults are suffering from obesity problems. Ninety-nine million people are overweight. An increasing number of people suffering from sleep disorders is likely to boost the demand of the market. Around 30% of the adult population are diagnosed with insomnia, which is the most common sleep disorder. Growing awareness over the availability of different devices among people is leveraging the growth rate of the market. Also, the increasing prevalence of chronic diseases is boosting up the demand of the market. OSA is the most common disorder among older people where this is merely fuelling the demand of the market. The presence of international key players in this country is significantly influencing the growth rate of the market. The rising number of diagnostic procedures that evaluate to improve the proper treatment procedures for sleep disorders is lavishing the demand for sleep apnea devices in the United States.

This research report on the North America Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories.

By Diagnostic Devices: 

• Polysomnography Devices     
  • Ambulatory PSG Devices     
  • Clinical PSG Devices  
• Respiratory Polygraphs
• Oximeters
  • Single-Channel Screening Devices (Pulse Oximeters)   
  • Fingertip Pulse Oximeters    
  • Handheld Pulse Oximeters    
  • Wrist-Worn Pulse Oximeters  
  • Tabletop Pulse Oximeters    
• Actigraphy Systems 

By Therapeutic Devices: 

• Positive Airway Pressure (PAP) Devices
  • CPAP Devices
  • APAP Devices
  • BPAP Devices
• Facial Interfaces       
  • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Full-Face Masks
• Adaptive Servo-Ventilation Instruments (ASV)  
• Airway Clearance Systems     
• Oxygen Concentrators
  • Stationary Concentrators     
  • Portable Concentrators       
• Accessories   
  • Pillows       
  • Chin Restraints       
  • Mask Cleaning Wipes
  • Other Accessories    
• Oral Appliances
  • Mandibular Advancement Devices    
  • Tongue Retaining Devices

By Country: 

• The United States
• Canada
• Rest of North America

Regionally, North America captures around 40% of the global market share. North America is leading with the highest shares in the global sleep apnea devices market. Increasing investments in the development of innovative devices is a major factor for the market to grow in this region.

The USA sleep apnea devices market is currently dominating the North American market and is presumed to contribute the largest share of revenues to the market during the forecast period. The factors contributing to the growth of the sleep apnea devices market in North America are the increasing account of sleeping disorders and the obesity population, leading to rising demand for sleep apnea devices, technological advancements, and key market players.

The Canadian sleep apnea devices market contributes a significant share of revenues to the North American sleep apnea devices market. It is expected to maintain the trend due to inappropriate sleeping habits, increasing focus of key market players in R&D activities in this region to develop novel and innovative techniques and therapeutic procedures.

Prominent Companies leading the North America Sleep Apnea Devices Market are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.).